AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22037770 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in cannabis use
Number of subjects: 267
Study 22037770 — intervention group
Group type: COMPARATOR
Intervention: Other substance use
Number of subjects: 267
Study 21442659 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training program (4 weeks, 3 sessions per week, 45 minutes each, using multimedia software and paper-and-pencil exercises)
Number of subjects: 28
Study 21442659 — intervention group
Group type: COMPARATOR
Intervention: Speech therapy (control group)
Number of subjects: 28
Study 17698933 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple imputation
Number of subjects: 0
Study 17698933 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverse probability weighting
Number of subjects: 0
Study 17698933 — intervention group
Group type: EXPERIMENTAL
Intervention: Doubly robust (DR) extension
Number of subjects: 0
Study 17698933 — intervention group
Group type: COMPARATOR
Intervention: Extreme case analysis
Number of subjects: 0
Study 17698933 — intervention group
Group type: COMPARATOR
Intervention: Hot-deck imputation
Number of subjects: 0
Study 17698933 — intervention group
Group type: COMPARATOR
Intervention: Single and multiple imputation
Number of subjects: 0
Study 17698933 — intervention group
Group type: COMPARATOR
Intervention: Likelihood based methods
Number of subjects: 0
Study 17032348 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole, clarithromycin, tetracycline and metronidazole (ECTM group, n = 46)
Number of subjects: 93
Study 17032348 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole, bismuth subcitrate, tetracycline and metronidazole (EBTM group, n = 47)
Number of subjects: 93
Study 17032348 — intervention group
Group type: COMPARATOR
Intervention: EBTM group (metronidazole-resistant strains)
Number of subjects: 93
Study 17032348 — intervention group
Group type: EXPERIMENTAL
Intervention: ECTM group (metronidazole-resistant strains)
Number of subjects: 93
Study 14610494 — intervention group
Group type: COMPARATOR
Intervention: Aspirin challenge
Number of subjects: 23
Study 11345031 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg Ukrain (5 mg every second day, 10 injections altogether)
Number of subjects: 50
Study 11345031 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg Ukrain (10 mg every second day, 10 injections altogether)
Number of subjects: 50
Study 8627888 — intervention group
Group type: EXPERIMENTAL
Intervention: EGS-I (original device)
Number of subjects: 46
Study 8627888 — intervention group
Group type: EXPERIMENTAL
Intervention: EGS-II (revised over-the-wire system)
Number of subjects: 46
Study 8627888 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention (both devices)
Number of subjects: 46
Study 1597518 — intervention group
Group type: EXPERIMENTAL
Intervention: Anistreplase
Number of subjects: 22
Study 1597518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 3911832 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (350,000 to 500,000 IU daily)
Number of subjects: 100
Study 3911832 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (high dose)
Number of subjects: 100
Study 30696254 — intervention group
Group type: EXPERIMENTAL
Intervention: Let's Talk About Children plus treatment as usual (n=20)
Number of subjects: 39
Study 30696254 — intervention group
Group type: COMPARATOR
Intervention: Wait list control (treatment as usual) (n=19)
Number of subjects: 39
Study 29931423 — intervention group
Group type: COMPARATOR
Intervention: Synbiotic supplementation
Number of subjects: 120
Study 29931423 — intervention group
Group type: COMPARATOR
Intervention: Probiotics supplementation
Number of subjects: 120
Study 26860879 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Psychosocial Intervention (BPI) delivered over 5 weeks, including counseling sessions and telephone follow-up, in addition to usual service.
Number of subjects: 65
Study 26860879 — intervention group
Group type: COMPARATOR
Intervention: Usual service (Control group)
Number of subjects: 65
Study 24973002 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLf) oral spray and oral piroxicam
Number of subjects: 13
Study 24973002 — intervention group
Group type: COMPARATOR
Intervention: Oral piroxicam
Number of subjects: 13
Study 24973002 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLf) oral spray and piroxicam
Number of subjects: 13
Study 22124619 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based participatory research (CBPR) framework for tobacco cessation intervention
Number of subjects: 0
Study 20643325 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot and hand massage
Number of subjects: 0
Study 20643325 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 17978643 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar support continuous passive motion (CPM) device
Number of subjects: 31
Study 17978643 — intervention group
Group type: EXPERIMENTAL
Intervention: Static lumbar support
Number of subjects: 31
Study 17978643 — intervention group
Group type: COMPARATOR
Intervention: No lumbar support
Number of subjects: 31
Study 17978643 — intervention group
Group type: COMPARATOR
Intervention: Fixed lumbar support
Number of subjects: 31
Study 17978643 — intervention group
Group type: COMPARATOR
Intervention: Lumbar support CPM
Number of subjects: 31
Study 16321598 — intervention group
Group type: EXPERIMENTAL
Intervention: Foods enriched in long-chain n-3 fatty acids (1 g/day)
Number of subjects: 85
Study 16321598 — intervention group
Group type: COMPARATOR
Intervention: Control foods (not enriched)
Number of subjects: 85
Study 11923244 — intervention group
Group type: EXPERIMENTAL
Intervention: FITC‐dextran (nonpenetrating fluorescent probe)
Number of subjects: 15
Study 11923244 — intervention group
Group type: COMPARATOR
Intervention: Buffered saline (control)
Number of subjects: 15
Study 11923244 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-viscosity solutions (eta = 2.7‐7.7 mPa/sec)
Number of subjects: 15
Study 11923244 — intervention group
Group type: EXPERIMENTAL
Intervention: High-viscosity gel (eta approximately equal 30,000 mPa/sec)
Number of subjects: 15
Study 11923244 — intervention group
Group type: EXPERIMENTAL
Intervention: Method repeatability
Number of subjects: 15
Study 9485066 — intervention group
Group type: EXPERIMENTAL
Intervention: SCA1 carriers (2 symptomatic, 2 asymptomatic)
Number of subjects: 10
Study 9485066 — intervention group
Group type: EXPERIMENTAL
Intervention: SCA1 carriers
Number of subjects: 10
Study 9485066 — intervention group
Group type: COMPARATOR
Intervention: Control group of 10 healthy volunteers
Number of subjects: 10
Study 8553083 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (135 mg/m2) and high-dose 5-fluorouracil (1.5-2.0 g/m2) with folinic acid (500 mg/m2) administered for 6 weeks, with paclitaxel given on days 1 and 22.
Number of subjects: 46
Study 8553083 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel and weekly high-dose 5-FU/FA regimen
Number of subjects: 46
Study 8553083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose level 4 (500 mg/m2 FA, 2.0 g/m2 5-FU, and 175 mg/m2 paclitaxel)
Number of subjects: 46
Study 2652842 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 76
Study 2652842 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 76
Study 1175145 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleural drainage with the instillation of radioactive colloidal chromic phosphate (PD + 32P) for 72 hours
Number of subjects: 67
Study 1175145 — intervention group
Group type: COMPARATOR
Intervention: Pleural drainage alone (PD) for 72 hours
Number of subjects: 67
Study 1175145 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy
Number of subjects: 67
Study 31296602 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightning Process, a neurolinguistic programming intervention, details on dosage and duration not available.
Number of subjects: 0
Study 28251152 — intervention group
Group type: EXPERIMENTAL
Intervention: MOSQ‐TSP
Number of subjects: 68
Study 28251152 — intervention group
Group type: COMPARATOR
Intervention: CONV‐TSP
Number of subjects: 68
Study 25988365 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Behavioral Intervention for Tics (CBIT)
Number of subjects: 240
Study 25988365 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation and Supportive Therapy (PST)
Number of subjects: 240
Study 23127204 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous progesterone formulation (100 mg) administered by subcutaneous injection
Number of subjects: 61
Study 23127204 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous progesterone formulation (25 mg and 50 mg) administered by subcutaneous injection once daily for 11 days
Number of subjects: 61
Study 23127204 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular reference oily product
Number of subjects: 61
Study 21854290 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg buprenorphine
Number of subjects: 516
Study 21854290 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg buprenorphine
Number of subjects: 516
Study 21854290 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 mg buprenorphine
Number of subjects: 516
Study 19587078 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic questionnaire score indicating CTS diagnosis
Number of subjects: 152
Study 19587078 — intervention group
Group type: EXPERIMENTAL
Intervention: Management model based on questionnaire score
Number of subjects: 152
Study 19587078 — intervention group
Group type: COMPARATOR
Intervention: Nerve conduction studies (NCS)
Number of subjects: 152
Study 19587078 — intervention group
Group type: EXPERIMENTAL
Intervention: Carpal tunnel release surgery
Number of subjects: 152
Study 17242854 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Education Program (AEP); one-day workshop and two follow-up telephone calls.
Number of subjects: 64
Study 17242854 — intervention group
Group type: COMPARATOR
Intervention: Delayed Asthma Education Program (control group).
Number of subjects: 64
Study 14665554 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES) solution
Number of subjects: 40
Study 11687764 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute sodium bicarbonate ingestion (0.5 g x kg(‐1) body mass)
Number of subjects: 8
Study 11687764 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic sodium bicarbonate ingestion (0.5 g x kg(‐1) body mass daily for six days)
Number of subjects: 8
Study 11687764 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 8
Study 9140693 — intervention group
Group type: EXPERIMENTAL
Intervention: Procainamide (bid formulation) 1000, 2000, or 4000 mg/d
Number of subjects: 99
Study 9140693 — intervention group
Group type: COMPARATOR
Intervention: Procainamide (qid formulation)
Number of subjects: 99
Study 9140693 — intervention group
Group type: EXPERIMENTAL
Intervention: Procainamide (bid formulation)
Number of subjects: 99
Study 8314137 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment
Number of subjects: 93
Study 8314137 — intervention group
Group type: COMPARATOR
Intervention: Nontreated
Number of subjects: 93
Study 3328284 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg x 2 for 4-8 weeks (up to 12 weeks for gastric ulcers)
Number of subjects: 647
Study 3328284 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate 1 g x 4 for 4-8 weeks (up to 12 weeks for gastric ulcers)
Number of subjects: 647
Study 3328284 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 647
Study 3328284 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate
Number of subjects: 647
Study 31770758 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTX)
Number of subjects: 104
Study 31770758 — intervention group
Group type: COMPARATOR
Intervention: No parathyroidectomy (non-PTX)
Number of subjects: 104
Study 27849419 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse dexamethasone (group D)
Number of subjects: 30
Study 27849419 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse cyclophosphamide (group C)
Number of subjects: 30
Study 27849419 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (pulse group DCP)
Number of subjects: 30
Study 27849419 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study 27504739 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline methylglyoxal
Number of subjects: 1481
Study 27504739 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in methylglyoxal during 6 years of follow-up
Number of subjects: 1481
Study 24997826 — intervention group
Group type: EXPERIMENTAL
Intervention: Piglitazone
Number of subjects: 60
Study 24997826 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 60
Study 24997826 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study 22238468 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-positive women
Number of subjects: 188
Study 22238468 — intervention group
Group type: COMPARATOR
Intervention: HIV-negative women
Number of subjects: 188
Study 22238468 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with cord P. falciparum infection
Number of subjects: 188
Study 20863330 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (50 mg/d)
Number of subjects: 99
Study 20863330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 18038223 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence condition (overnight smoking abstinence)
Number of subjects: 26
Study 18038223 — intervention group
Group type: COMPARATOR
Intervention: Satiated condition (participants smoked up to and during the session)
Number of subjects: 26
Study 18038223 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive measures (e.g., rapid visual information processing task, cued Go/No-Go task)
Number of subjects: 26
Study 16148558 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic variceal ligation
Number of subjects: 60
Study 16148558 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 60
Study 11951074 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxofylline 400 mg t.i.d.
Number of subjects: 346
Study 11951074 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline 250 mg t.i.d. (active control)
Number of subjects: 346
Study 11951074 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxofylline 200 mg t.i.d.
Number of subjects: 346
Study 11951074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 346
Study 11951074 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline 250 mg t.i.d.
Number of subjects: 346
Study 10069631 — intervention group
Group type: EXPERIMENTAL
Intervention: Transumbilical cholecystectomy through 2 ports
Number of subjects: 90
Study 10069631 — intervention group
Group type: COMPARATOR
Intervention: Standard laparoscopic cholecystectomy through 4 ports
Number of subjects: 90
Study 7733026 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmolein
Number of subjects: 21
Study 7733026 — intervention group
Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 21
Study 1790160 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 1134
Study 1790160 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 1134
Study 1790160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1134
Study 7021747 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke unit rehabilitation
Number of subjects: 0
Study 7021747 — intervention group
Group type: COMPARATOR
Intervention: Medical unit rehabilitation
Number of subjects: 0
Study 30878017 — intervention group
Group type: EXPERIMENTAL
Intervention: Patisiran, 0.3 mg/kg, via intravenous infusion once every 3 weeks for 18 months
Number of subjects: 126
Study 30878017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 30878017 — intervention group
Group type: EXPERIMENTAL
Intervention: Patisiran
Number of subjects: 126
Study 29630009 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy lifestyle package (antenatal behavior change intervention supported by smartphone application technology)
Number of subjects: 565
Study 29630009 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 565
Study 27876004 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg from recruitment until 36+0 weeks or delivery, whichever occurs sooner, in addition to standard high risk care (which includes aspirin 100 mg daily and calcium 1000-1500 mg daily)
Number of subjects: 0
Study 27876004 — intervention group
Group type: COMPARATOR
Intervention: Standard high risk care (which includes aspirin 100 mg daily and calcium 1000-1500 mg daily)
Number of subjects: 0
Study 23795582 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surfactant (ES) treatment (200 mg/kg Curosurf® within 1 hour after birth)
Number of subjects: 159
Study 23795582 — intervention group
Group type: COMPARATOR
Intervention: Late selective (LS) treatment (200 mg/kg Curosurf® within the first 6 hours of life if needed)
Number of subjects: 159
Study 23795582 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surfactant (ES) treatment
Number of subjects: 159
Study 23795582 — intervention group
Group type: COMPARATOR
Intervention: Late selective (LS) treatment
Number of subjects: 159
Study 23795582 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ES and LS treatments
Number of subjects: 159
Study 22649143 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 252
Study 22649143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study 19296774 — intervention group
Group type: COMPARATOR
Intervention: Adaptive design trials
Number of subjects: 0
Study 19296774 — intervention group
Group type: COMPARATOR
Intervention: Adaptive sequence of trials
Number of subjects: 0
Study 17190759 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (9-36)amide (5 pmol/kg body wt/min)
Number of subjects: 6
Study 17190759 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 6
Study 16773435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking for 40 years
Number of subjects: 89835
Study 16773435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking intensity of 40 cigarettes per day
Number of subjects: 89835
Study 16773435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative exposure of 40 pack-years
Number of subjects: 89835
Study 16773435 — intervention group
Group type: EXPERIMENTAL
Intervention: Latency of cigarette smoking for 40 years since commencement
Number of subjects: 89835
Study 16773435 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking initiation before first full-term pregnancy (more than 5 years of smoking)
Number of subjects: 89835
Study 12829148 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid immobilization (RI) devices
Number of subjects: 100
Study 12829148 — intervention group
Group type: COMPARATOR
Intervention: Control group (no immobilization devices)
Number of subjects: 100
Study 11054225 — intervention group
Group type: EXPERIMENTAL
Intervention: SCD Response Compression System
Number of subjects: 12
Study 11054225 — intervention group
Group type: COMPARATOR
Intervention: SCD Sequel Compression System
Number of subjects: 12
Study 9026570 — intervention group
Group type: EXPERIMENTAL
Intervention: High myopia group (42 patients)
Number of subjects: 46
Study 9026570 — intervention group
Group type: EXPERIMENTAL
Intervention: High myopia with retinal detachment surgery group (4 patients)
Number of subjects: 46
Study 1326031 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery-only
Number of subjects: 0
Study 1326031 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery/relaxation
Number of subjects: 0
Study 1326031 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 0
Study 1326031 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiotaped imagery
Number of subjects: 0
Study 6340424 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml cod liver oil (CLO) daily for 6 weeks
Number of subjects: 0
Study 31631501 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 143
Study 31631501 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 143
Study 31631501 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 143
Study 30076623 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted horses
Number of subjects: 0
Study 30076623 — intervention group
Group type: COMPARATOR
Intervention: Fed horses
Number of subjects: 0
Study 27530758 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional training of the paretic upper limb combined with anodic transcranial stimulation
Number of subjects: 34
Study 27530758 — intervention group
Group type: COMPARATOR
Intervention: Functional training of the paretic upper limb combined with sham transcranial stimulation
Number of subjects: 34
Study 25509734 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at three lines of cervical Jiaji (EX-B 2), once a day for 10 days, two sessions total.
Number of subjects: 300
Study 25509734 — intervention group
Group type: COMPARATOR
Intervention: Jingfukang granules, one bag three times a day for 10 days, two sessions total.
Number of subjects: 300
Study 23128491 — intervention group
Group type: EXPERIMENTAL
Intervention: cHerbst appliance
Number of subjects: 40
Study 23128491 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated Class II subjects)
Number of subjects: 40
Study 20861632 — intervention group
Group type: EXPERIMENTAL
Intervention: liquid dentifrice, 1,100 ppm F, pH 4.5
Number of subjects: 1402
Study 20861632 — intervention group
Group type: EXPERIMENTAL
Intervention: liquid dentifrice, 1,100 ppm F, pH 7.0
Number of subjects: 1402
Study 20861632 — intervention group
Group type: EXPERIMENTAL
Intervention: liquid dentifrice, 550 ppm F, pH 4.5
Number of subjects: 1402
Study 20861632 — intervention group
Group type: EXPERIMENTAL
Intervention: toothpaste, 1,100 ppm F, pH 7.0
Number of subjects: 1402
Study 16983507 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (Treatment A)
Number of subjects: 36
Study 16983507 — intervention group
Group type: COMPARATOR
Intervention: Control (Treatment B)
Number of subjects: 36
Study 16276165 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam (n = 150) at 0.09 microg x kg x min
Number of subjects: 300
Study 16276165 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 150)
Number of subjects: 300